propranolol has been researched along with Anxiety in 143 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examined whether acute propranolol treatment prevented posttraumatic stress disorder (PTSD), anxiety, and depression in children hospitalized in the pediatric intensive care unit for large burns." | 9.27 | Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns? ( Herndon, DN; Holzer, CE; Humphries, HF; Meyer, WJ; Rosenberg, L; Rosenberg, M; Sharp, S; Thomas, CR, 2018) |
| "To investigate the interplay between induced anxiety and WM, we pharmacologically manipulated either anxiety or cognition, using single doses of 40 mg propranolol (PRO), 20 mg methylphenidate (MPH), or placebo (PLA)." | 9.22 | The effects of methylphenidate and propranolol on the interplay between induced-anxiety and working memory. ( Davis, A; Ernst, M; Grillon, C; Lago, T, 2016) |
| " Of these 11 (not taking propranolol), nine (82 percent) developed postsurgical dissatisfaction syndrome." | 9.14 | Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study. ( Gruber, RP; Pitman, RK; Roberts, C; Schooler, W, 2009) |
| "To find out if propranolol, a non-cardioselective beta-blocker, can reduce the anxiety associated with day case surgery." | 9.08 | Propranolol reduces the anxiety associated with day case surgery. ( Fitzpatrick, G; Gillen, P; Keane, FB; Mealy, K; Ngeh, N; Tanner, A, 1996) |
| "A double-blind crossover comparison is reported of the effects of alprazolam and placebo on anxiety and angina in 27 ambulatory outpatients with angina pectoris stabilized on propranolol." | 9.06 | Alprazolam as an adjunct to propranolol in anxious outpatients with stable angina pectoris. ( Blatt, M; Chernoff, RW; Mendels, J, 1986) |
| "Since 1964, of 725 patients presenting with anxiety syndromes, 513 were treated with propranolol for periods of several days to over 10 years, some intermittently, others virtually without interruption." | 9.04 | Propranolol in the treatment of anxiety. ( Suzman, MM, 1976) |
| "The efficacy of oxprenolol (Trasicor) and propranolol in controlling anxiety was compared in a double-blind study of patients with anxiety and tension." | 9.04 | Oxprenolol and propranolol in anxiety states. A double-blind comparative study. ( Becker, AL, 1976) |
| "In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)." | 9.04 | [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978) |
| "Propranolol is often prescribed to younger people with exam-related performance anxiety." | 8.98 | [Limited evidence for effect and safety of propranolol for exam-related anxiety]. ( Bøgevig, S; Dalhoff, KP; Petersen, KM; Petersen, TS; Vinther, S, 2018) |
| "The authors review the available literature on the use of propranolol in the treatment of anxiety disorders." | 8.77 | The use of propranolol in the treatment of anxiety disorders. ( Fonte, RJ; Stevenson, JM, 1985) |
| "In this study, we evaluated the performance of dopamine beta-hydroxylase knockout (Dbh -/-) mice, which lack norepinephrine (NE), in the elevated plus maze (EPM) to examine the contribution of noradrenergic signaling to cocaine-induced anxiety." | 7.74 | Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety. ( Liles, LC; Schank, JR; Weinshenker, D, 2008) |
| "This study examined whether acute propranolol treatment prevented posttraumatic stress disorder (PTSD), anxiety, and depression in children hospitalized in the pediatric intensive care unit for large burns." | 5.27 | Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns? ( Herndon, DN; Holzer, CE; Humphries, HF; Meyer, WJ; Rosenberg, L; Rosenberg, M; Sharp, S; Thomas, CR, 2018) |
| "Treatment with propranolol hydrochloride produced longterm symptomatic relief." | 5.26 | Somatic anxiety attacks and propranolol. ( Easton, JD; Sherman, DG, 1976) |
| " In experiment 2, we found that LPP amplitude was modulated by the β-blocker propranolol in a direction dependent on subjects' level of trait anxiety: In participants with lower trait anxiety, propranolol led to a (nonsignificant) decrease in the LPP modulation; in participants with higher trait anxiety, propranolol increased the emotion-related LPP modulation." | 5.16 | Beta receptor-mediated modulation of the late positive potential in humans. ( Boot, N; Brown, SB; de Rover, M; Hajcak, G; Nieuwenhuis, S; van der Wee, NJ; van Noorden, MS, 2012) |
| "This was a double blind, placebo-controlled, 4-way cross-over study in 12 healthy volunteer subjects of the acute effects of three drugs each of which are used in the clinic to treat some forms of anxiety: propranolol 40 mg, hydroxyzine 25 mg, flupentixol 0." | 5.14 | The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures. ( Bailey, JE; Nutt, DJ; Papadopoulos, A; Rich, A, 2010) |
| " Of these 11 (not taking propranolol), nine (82 percent) developed postsurgical dissatisfaction syndrome." | 5.14 | Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study. ( Gruber, RP; Pitman, RK; Roberts, C; Schooler, W, 2009) |
| "Our findings provide the missing link between the anxiolytic potential of propranolol and the biological basis of β-noradrenergic activation in the human BLA as a key target for the pharmacological inhibition of anxiety neurocircuitry." | 5.14 | Human amygdala reactivity is diminished by the β-noradrenergic antagonist propranolol. ( Hurlemann, R; Kendrick, KM; Keysers, C; Kukolja, J; Maier, W; Musshoff, F; Onur, OA; Rehme, AK; Santoro, SC; Schmidt, C; Schnell, K; Walter, H, 2010) |
| "Compared to placebo, resting "tension", "depression", and "total mood disturbance" were significantly higher on propranolol 80 mg, but all were reduced with exercise." | 5.08 | Acute effects of beta blockade and exercise on mood and anxiety. ( Eagles, C; Ferner, R; Head, A; Kendall, MJ, 1996) |
| "To determine whether propranolol can decrease surgical tremor and anxiety in residents performing ocular microsurgery without impairing patient or physician safety." | 5.08 | The effect of propranolol versus placebo on resident surgical performance. ( Anderson, RJ; Deutsch, TA; Elman, MJ; Fiscella, R; Noth, J; Nyberg, M; Packo, K; Sugar, J, 1998) |
| "The effectiveness of propranolol, a nonsedating anxiolytic premedication, was studied by monitoring preoperative anxiety and postoperative recovery of cognitive function in 92 healthy ASA physical status I females aged 15-42 yr undergoing outpatient dilatation and curettage (D&C) for therapeutic abortion." | 5.07 | A comparison of propranolol and diazepam for preoperative anxiolysis. ( Chung, F; Dyck, JB, 1991) |
| "A double-blind crossover comparison is reported of the effects of alprazolam and placebo on anxiety and angina in 27 ambulatory outpatients with angina pectoris stabilized on propranolol." | 5.06 | Alprazolam as an adjunct to propranolol in anxious outpatients with stable angina pectoris. ( Blatt, M; Chernoff, RW; Mendels, J, 1986) |
| "Twelve male patients, with a primary complaint of premature ejaculation in a setting of chronic anxiety with prominent somatic manifestations, participated in a double-blind trial: propranolol against placebo." | 5.05 | A clinical trial of the beta blocker propranolol in premature ejaculation. ( Cooper, AJ; Magnus, RV, 1984) |
| "In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)." | 5.04 | [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978) |
| "Since 1964, of 725 patients presenting with anxiety syndromes, 513 were treated with propranolol for periods of several days to over 10 years, some intermittently, others virtually without interruption." | 5.04 | Propranolol in the treatment of anxiety. ( Suzman, MM, 1976) |
| "The authors review the available literature on the use of propranolol in the treatment of anxiety disorders." | 4.77 | The use of propranolol in the treatment of anxiety disorders. ( Fonte, RJ; Stevenson, JM, 1985) |
| "In this study, we evaluated the performance of dopamine beta-hydroxylase knockout (Dbh -/-) mice, which lack norepinephrine (NE), in the elevated plus maze (EPM) to examine the contribution of noradrenergic signaling to cocaine-induced anxiety." | 3.74 | Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety. ( Liles, LC; Schank, JR; Weinshenker, D, 2008) |
| "The effect of intracerebrally injected propranolol was measured in the elevated plus-maze, an animal model of anxiety." | 3.67 | Serotonergic mediation of the anxiolytic effect of intracerebrally injected propranolol measured in the elevated plus-maze. ( Audi, EA; de-Oliveira, CE; Graeff, FG, 1989) |
| "The purpose of this study was to determine the mechanism by which caffeine increases anxiety." | 3.67 | Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. ( Baldwin, HA; File, SE, 1989) |
| "A patient developed severe anxiety, moodswing, depression, and thinking disorder 24 hours after abruptly stopping oxazepam, of which he had taken 30 mg 3 times a day for two months, for anxiety and panic attacks." | 3.66 | Abstinence syndrome from therapeutic doses of oxazepam. ( Kulik, AV; Wilbur, R, 1983) |
| " It is concluded that, at the dosage used, propranolol, unlike diazepam, does not affect the central mechanisms determining CNV magnitude or subjective anxiety." | 2.64 | A comparison of some physiological and psychological effects of propranolol and diazepam in normal subjects. ( Ashton, H; Millman, JE; Telford, R; Thompson, JW, 1976) |
| " Other reported effects are toxic confusional states and psychotic reactions." | 2.36 | Psychiatric side effects of antihypertensive drugs other than reserpine. ( Fleminger, R; Paykel, ES; Watson, JP, 1982) |
| "Pretreatment with atropine, phenoxybenzamine, propranolol and bicuculline did not influence the action of PACAP-38 on the time spent in open arms." | 1.42 | Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats. ( Adamik, A; Telegdy, G, 2015) |
| "Propranolol pretreatment (2." | 1.29 | Beta-adrenergic receptors are involved in stress-related behavioral changes. ( Dunn, AJ; Gorman, AL, 1993) |
| "Propranolol 40 mg was compared with a matched placebo tablet in its effect on the performance of anxious and non-anxious human volunteers." | 1.27 | The effect of beta adrenergic blocking drugs on speakers' performance and memory. ( Davie, I; Hartley, LR; Spencer, DJ; Ungapen, S, 1983) |
| "They are effective in any fast arrhythmia." | 1.26 | Present state of alpha and beta adrenergic drugs III. Beta blocking agents. ( Ahlquist, RP, 1977) |
| "Treatment with propranolol hydrochloride produced longterm symptomatic relief." | 1.26 | Somatic anxiety attacks and propranolol. ( Easton, JD; Sherman, DG, 1976) |
| "Patient compliance can be improved by reducing the complexity of drug dosage and by better labeling, packaging and informational exchange." | 1.26 | Once-a-day drug regimen for psychiatric patients. ( Hasan, MK; Mooney, RP, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 85 (59.44) | 18.7374 |
| 1990's | 13 (9.09) | 18.2507 |
| 2000's | 14 (9.79) | 29.6817 |
| 2010's | 29 (20.28) | 24.3611 |
| 2020's | 2 (1.40) | 2.80 |
| Authors | Studies |
|---|---|
| Szeleszczuk, Ł | 1 |
| Frączkowski, D | 1 |
| Lanfranconi, S | 1 |
| Scola, E | 1 |
| Bertani, GA | 1 |
| Zarino, B | 1 |
| Pallini, R | 1 |
| d'Alessandris, G | 1 |
| Mazzon, E | 1 |
| Marino, S | 1 |
| Carriero, MR | 1 |
| Scelzo, E | 1 |
| Faragò, G | 1 |
| Castori, M | 1 |
| Fusco, C | 1 |
| Petracca, A | 1 |
| d'Agruma, L | 1 |
| Tassi, L | 1 |
| d'Orio, P | 1 |
| Lampugnani, MG | 1 |
| Nicolis, EB | 1 |
| Vasamì, A | 1 |
| Novelli, D | 1 |
| Torri, V | 1 |
| Meessen, JMTA | 1 |
| Al-Shahi Salman, R | 1 |
| Dejana, E | 1 |
| Latini, R | 1 |
| Rosenberg, L | 1 |
| Rosenberg, M | 1 |
| Sharp, S | 1 |
| Thomas, CR | 1 |
| Humphries, HF | 1 |
| Holzer, CE | 1 |
| Herndon, DN | 1 |
| Meyer, WJ | 1 |
| Rorabaugh, BR | 1 |
| Bui, AD | 1 |
| Seeley, SL | 1 |
| Eisenmann, ED | 1 |
| Rose, RM | 1 |
| Johnson, BL | 1 |
| Huntley, MR | 1 |
| Heikkila, ME | 1 |
| Zoladz, PR | 1 |
| Vinther, S | 1 |
| Bøgevig, S | 1 |
| Petersen, TS | 1 |
| Dalhoff, KP | 1 |
| Petersen, KM | 1 |
| Khadke, VV | 1 |
| Khadke, SV | 1 |
| Khare, A | 1 |
| Valizadegan, F | 1 |
| Oryan, S | 1 |
| Nasehi, M | 1 |
| Zarrindast, MR | 1 |
| Telegdy, G | 7 |
| Adamik, A | 3 |
| Soeter, M | 1 |
| Kindt, M | 2 |
| Jászberényi, M | 2 |
| Palotai, M | 2 |
| Kline, RH | 1 |
| Exposto, FG | 1 |
| O'Buckley, SC | 1 |
| Westlund, KN | 1 |
| Nackley, AG | 1 |
| Riddell, NE | 1 |
| Burns, VE | 1 |
| Wallace, GR | 1 |
| Edwards, KM | 1 |
| Drayson, M | 1 |
| Redwine, LS | 1 |
| Hong, S | 1 |
| Bui, JC | 1 |
| Fischer, JC | 1 |
| Mills, PJ | 1 |
| Bosch, JA | 1 |
| Skelly, MJ | 1 |
| Chappell, AE | 1 |
| Carter, E | 1 |
| Weiner, JL | 2 |
| de Rover, M | 2 |
| Brown, SB | 2 |
| Band, GP | 1 |
| Giltay, EJ | 1 |
| van Noorden, MS | 2 |
| van der Wee, NJ | 2 |
| Nieuwenhuis, S | 2 |
| Zamzow, RM | 2 |
| Ferguson, BJ | 2 |
| Stichter, JP | 1 |
| Porges, EC | 1 |
| Ragsdale, AS | 2 |
| Lewis, ML | 2 |
| Beversdorf, DQ | 2 |
| Ernst, M | 1 |
| Lago, T | 1 |
| Davis, A | 1 |
| Grillon, C | 1 |
| Stern, CA | 1 |
| Carobrez, AP | 1 |
| Bertoglio, LJ | 1 |
| Papadopoulos, A | 1 |
| Rich, A | 1 |
| Nutt, DJ | 1 |
| Bailey, JE | 1 |
| Gruber, RP | 1 |
| Roberts, C | 1 |
| Schooler, W | 1 |
| Pitman, RK | 1 |
| Rothwell, PE | 1 |
| Thomas, MJ | 1 |
| Gewirtz, JC | 1 |
| Drakaki, A | 1 |
| Habib, M | 1 |
| Sweeney, AT | 1 |
| Inagaki, H | 1 |
| Kiyokawa, Y | 1 |
| Takeuchi, Y | 1 |
| Mori, Y | 1 |
| Hurlemann, R | 1 |
| Walter, H | 1 |
| Rehme, AK | 1 |
| Kukolja, J | 1 |
| Santoro, SC | 1 |
| Schmidt, C | 1 |
| Schnell, K | 1 |
| Musshoff, F | 1 |
| Keysers, C | 1 |
| Maier, W | 1 |
| Kendrick, KM | 1 |
| Onur, OA | 1 |
| Silberman, Y | 1 |
| Ariwodola, OJ | 1 |
| Chappell, AM | 1 |
| Yorgason, JT | 1 |
| Cohen, H | 1 |
| Kaplan, Z | 1 |
| Koresh, O | 1 |
| Matar, MA | 1 |
| Geva, AB | 1 |
| Zohar, J | 1 |
| Boot, N | 1 |
| Hajcak, G | 1 |
| Ashton, H | 1 |
| Millman, JE | 1 |
| Telford, R | 1 |
| Thompson, JW | 1 |
| Bos, MG | 1 |
| Beckers, T | 1 |
| de Oliveira Citó, Mdo C | 1 |
| da Silva, FC | 1 |
| Silva, MI | 1 |
| Moura, BA | 1 |
| Macêdo, DS | 1 |
| Woods, DJ | 1 |
| Fonteles, MM | 1 |
| de Vasconcelos, SM | 1 |
| de Sousa, FC | 1 |
| Aykaç, A | 1 |
| Aydın, B | 1 |
| Cabadak, H | 1 |
| Gören, MZ | 1 |
| Hanke, ML | 1 |
| Powell, ND | 1 |
| Stiner, LM | 1 |
| Bailey, MT | 1 |
| Sheridan, JF | 1 |
| Fleminger, S | 2 |
| Greenwood, RJ | 2 |
| Oliver, DL | 2 |
| Talalaenko, AN | 1 |
| Pankrat'ev, DV | 1 |
| Goncharenko, NV | 1 |
| Zeller, A | 1 |
| Handschin, D | 1 |
| Gyr, N | 1 |
| Martina, B | 1 |
| Battegay, E | 1 |
| Fraser, I | 1 |
| Adamec, R | 1 |
| Muir, C | 1 |
| Grimes, M | 1 |
| Pearcey, K | 1 |
| Schank, JR | 1 |
| Liles, LC | 1 |
| Weinshenker, D | 1 |
| Schmidt, A | 1 |
| Karlson-Stiber, C | 1 |
| Pinter, EJ | 2 |
| Peterfy, G | 2 |
| Cleghorn, JM | 2 |
| Pattee, CJ | 2 |
| Harris, E | 1 |
| Hasan, MK | 1 |
| Mooney, RP | 1 |
| Corbett, JL | 1 |
| Brantigan, CO | 1 |
| Brantigan, TA | 1 |
| Joseph, N | 1 |
| Paykel, ES | 1 |
| Fleminger, R | 1 |
| Watson, JP | 1 |
| Bacher, NA | 1 |
| Lewis, HA | 1 |
| Cooper, AJ | 1 |
| Magnus, RV | 1 |
| Katerndahl, DA | 1 |
| Stiff, JL | 1 |
| Harris, DB | 1 |
| Hartley, LR | 1 |
| Ungapen, S | 1 |
| Davie, I | 1 |
| Spencer, DJ | 1 |
| Wilbur, R | 1 |
| Kulik, AV | 1 |
| Neumann, HJ | 1 |
| Becher, G | 1 |
| McLane, M | 1 |
| Krop, H | 1 |
| Mehta, J | 1 |
| Sachdev, P | 1 |
| Loneragan, C | 1 |
| Harris, GC | 1 |
| Aston-Jones, G | 1 |
| Gorman, AL | 1 |
| Dunn, AJ | 1 |
| Mealy, K | 1 |
| Ngeh, N | 1 |
| Gillen, P | 1 |
| Fitzpatrick, G | 1 |
| Keane, FB | 1 |
| Tanner, A | 1 |
| Head, A | 1 |
| Kendall, MJ | 1 |
| Ferner, R | 1 |
| Eagles, C | 1 |
| Biró, E | 1 |
| Penke, B | 1 |
| Elman, MJ | 1 |
| Sugar, J | 1 |
| Fiscella, R | 1 |
| Deutsch, TA | 1 |
| Noth, J | 1 |
| Nyberg, M | 1 |
| Packo, K | 1 |
| Anderson, RJ | 1 |
| Berger, U | 1 |
| Piccirillo, G | 1 |
| Cacciafesta, M | 1 |
| Lionetti, M | 1 |
| Nocco, M | 1 |
| Di Giuseppe, V | 1 |
| Moisè, A | 1 |
| Naso, C | 1 |
| Marigliano, V | 1 |
| Walker, DL | 1 |
| Davis, M | 1 |
| Kabes, J | 1 |
| Dostal, T | 1 |
| Taussigová, D | 1 |
| Kabesová, L | 1 |
| Silverstone, T | 1 |
| Turner, P | 4 |
| Ahlquist, RP | 1 |
| Wheatley, D | 1 |
| Conway, J | 1 |
| Greenwood, DT | 2 |
| Middlemiss, DN | 1 |
| Cole, JO | 2 |
| Lubbe, WF | 1 |
| Sherman, DG | 2 |
| Easton, JD | 2 |
| Piris, P | 1 |
| Beaughard, M | 1 |
| Cosnier, D | 1 |
| Labrid, C | 1 |
| Mitrani, A | 1 |
| Oettinger, M | 1 |
| Abinader, EG | 1 |
| Sharf, M | 1 |
| Klein, A | 1 |
| Schoenen, J | 1 |
| Delwaide, PJ | 1 |
| Strian, F | 1 |
| Klicpera, C | 1 |
| Ebel, H | 1 |
| Lübke, H | 1 |
| Klaus, D | 1 |
| Zehner, J | 1 |
| Witzgall, H | 1 |
| Becker, AL | 1 |
| Suzman, MM | 1 |
| Faigel, HC | 1 |
| Jensen, VK | 1 |
| Dyck, JB | 1 |
| Chung, F | 1 |
| Audi, EA | 2 |
| de-Oliveira, RM | 1 |
| de-Oliveira, CE | 2 |
| Graeff, FG | 2 |
| Richter, A | 1 |
| Schumann, NP | 1 |
| Zwiener, U | 1 |
| Baldwin, HA | 2 |
| File, SE | 3 |
| Albus, M | 1 |
| Zellner, A | 1 |
| Bondy, B | 1 |
| Müller-Spahn, F | 1 |
| Engel, R | 1 |
| Ackenheil, M | 1 |
| Hitchcott, PK | 1 |
| Cole, BJ | 1 |
| Koob, GF | 1 |
| Noyes, R | 1 |
| Betts, TA | 1 |
| Knight, R | 1 |
| Crowe, A | 1 |
| Blake, A | 1 |
| Harvey, P | 1 |
| Mortiboy, D | 1 |
| Koella, WP | 1 |
| Risse, SC | 1 |
| Barnes, R | 1 |
| Lennane, KJ | 1 |
| Nakra, BR | 1 |
| Grossberg, GT | 1 |
| Lader, M | 2 |
| Delini-Stula, A | 1 |
| Hunn, C | 1 |
| Crawley, JN | 1 |
| Ninan, PT | 1 |
| Pickar, D | 1 |
| Chrousos, GP | 1 |
| Linnoila, M | 1 |
| Skolnick, P | 1 |
| Paul, SM | 1 |
| Hudson, CF | 1 |
| Mendels, J | 1 |
| Chernoff, RW | 1 |
| Blatt, M | 1 |
| Ziegler, DK | 1 |
| Hurwitz, A | 1 |
| Hassanein, RS | 1 |
| Kodanaz, HA | 1 |
| Preskorn, SH | 1 |
| Mason, J | 1 |
| Lister, RG | 1 |
| Fonte, RJ | 1 |
| Stevenson, JM | 1 |
| Fagerström, KO | 1 |
| Hugdahl, K | 1 |
| Lundström, N | 1 |
| Bonn, JA | 2 |
| Brewer, C | 1 |
| Gardos, G | 1 |
| Volicer, L | 1 |
| Orzack, MH | 1 |
| Oliff, AC | 1 |
| Whitlock, FA | 1 |
| Price, J | 1 |
| Bergamaschi, M | 2 |
| Longoni, AM | 2 |
| Granville-Grossman, KL | 2 |
| Frick, MH | 1 |
| Heikkilä, J | 1 |
| Kahanpää, A | 1 |
| Ashton, F | 1 |
| Bainbridge, JG | 1 |
| Greenblatt, DJ | 1 |
| Shader, RI | 1 |
| Clark, DW | 1 |
| Goldberg, LI | 1 |
| Gallant, DM | 1 |
| Swanson, WC | 1 |
| Guerrero-Figueroa, R | 1 |
| Bagley, C | 2 |
| Greer, S | 2 |
| Ramsay, I | 2 |
| Stone, WN | 1 |
| Gleser, GC | 1 |
| Gottschalk, LA | 1 |
| Dollery, CT | 1 |
| George, C | 1 |
| Drew, LR | 1 |
| Moon, JR | 1 |
| Buchanan, FH | 1 |
| Sepinwall, J | 1 |
| Grodsky, FS | 1 |
| Sullivan, JW | 1 |
| Cook, L | 1 |
| Conway, M | 2 |
| Carlsson, C | 1 |
| Johansson, T | 1 |
| Richardson, JS | 1 |
| Stacey, PD | 1 |
| Russo, NJ | 1 |
| Musty, RE | 1 |
| Wise, CD | 1 |
| Berger, BD | 1 |
| Stein, L | 1 |
| Jackson, WB | 1 |
| Marsden, CD | 1 |
| Gimlette, TM | 1 |
| McAllister, RG | 1 |
| Owen, DA | 1 |
| Miller, TN | 1 |
| Smith, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treat_CCM Clinical Trial A Multicenter Randomized Clinical Trial on Propranolol in Familial Cerebral Cavernous Malformation[NCT03589014] | Phase 2 | 71 participants (Actual) | Interventional | 2018-04-11 | Completed | ||
| Trial of Propranolol in Older Adults With Primary Progressive Aphasia[NCT06066710] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2024-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 reviews available for propranolol and Anxiety
| Article | Year |
|---|---|
Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder.
Topics: Anxiety; Anxiety Disorders; Humans; Propranolol; Stress Disorders, Post-Traumatic | 2022 |
[Limited evidence for effect and safety of propranolol for exam-related anxiety].
Topics: Adrenergic beta-Antagonists; Anxiety; Denmark; Humans; Propranolol | 2018 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidat | 2003 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidat | 2006 |
Psychiatric side effects of antihypertensive drugs other than reserpine.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Anxiety; Bethanidine; Clonidine; Debrisoquin; | 1982 |
Central nervous actions of beta-adrenoreceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Behavior; Central Nervous System; Central Nervous Sys | 1978 |
Clinical usefulness of the beta-adrenergic antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Anx | 1978 |
[Significance of autonomic arousal for the development and persistence of anxiety states (author's transl)].
Topics: Anxiety; Autonomic Nervous System; Humans; Propranolol; Psychophysiology; Relaxation Therapy | 1978 |
Beta-adrenergic blocking drugs in anxiety and stress.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Asthma; Benzodiazepine | 1985 |
CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.
Topics: Adrenergic beta-Antagonists; Amphetamine; Animals; Anxiety; Blood-Brain Barrier; Central Nervous Sys | 1985 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; | 1986 |
Treatment of benzodiazepine dependence.
Topics: Aged; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Cats; Drug Tolerance; Epilepsy; Female | 1986 |
The use of propranolol in the treatment of anxiety disorders.
Topics: Anxiety; Anxiety Disorders; Double-Blind Method; Heart Diseases; Humans; Mitral Valve Prolapse; Pani | 1985 |
Progress in anxiety states.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Anxiety; Aversive Therapy; Bicarbonates; | 1973 |
Use of beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Anxiety; Chlordiazepoxide; Di | 1974 |
On the psychopharmacology of beta adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anxiety; Arrhythmias, Cardiac; Cardiovascular Diseases | 1972 |
Propranolol--ten years from introduction.
Topics: Angina Pectoris; Antihypertensive Agents; Anxiety; Aortic Aneurysm; Arrhythmias, Cardiac; Cardiomyop | 1974 |
46 trials available for propranolol and Anxiety
| Article | Year |
|---|---|
Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Anxiety; Case-Control Studies; Depression; Disease Prog | 2020 |
Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns?
Topics: Adolescent; Adrenergic beta-Antagonists; Anxiety; Burns; Child; Depression; Female; Follow-Up Studie | 2018 |
Oral propranolol--efficacy and comparison of two doses for peri-operative anxiolysis.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Anxiety Agents; Anxiety; | 2012 |
High trait anxiety: a challenge for disrupting fear memory reconsolidation.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Fear; Female; Humans; Male; Memory; Propranolol | 2013 |
Beta receptor-mediated modulation of the oddball P3 but not error-related ERP components in humans.
Topics: Acoustic Stimulation; Adolescent; Adrenergic beta-Antagonists; Adult; Anxiety; Cross-Over Studies; D | 2015 |
Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aggression; Anxiety; Autism Spectrum Disorder; Auton | 2016 |
The effects of methylphenidate and propranolol on the interplay between induced-anxiety and working memory.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Attention; Central Nervous System Stimulants; Double-Bl | 2016 |
Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anxiety; Autism Spectrum Disorder; Autonomic Nervous | 2017 |
The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.
Topics: Administration, Inhalation; Adult; Anti-Anxiety Agents; Anxiety; Arousal; Blood Pressure; Carbon Dio | 2010 |
Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study.
Topics: Anxiety; Body Image; Depression; Double-Blind Method; Humans; Patient Satisfaction; Pilot Projects; | 2009 |
Human amygdala reactivity is diminished by the β-noradrenergic antagonist propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Amygdala; Anxiety; Double-Blind Method; Facial Expression; Fear; | 2010 |
Beta receptor-mediated modulation of the late positive potential in humans.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Alleles; Amygdala; Anxiety; Cross-Over Studies; Doub | 2012 |
A comparison of some physiological and psychological effects of propranolol and diazepam in normal subjects.
Topics: Adrenergic beta-Antagonists; Anxiety; Blood Pressure; Contingent Negative Variation; Diazepam; Elect | 1976 |
The effects of noradrenergic blockade on extinction in humans.
Topics: Acoustic Stimulation; Adrenergic beta-Antagonists; Anxiety; Blood Pressure; Conditioning, Classical; | 2012 |
beta-Adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Anxiety; Clinical Trials as Topic; Costs and Cost Analysis; Humans; Pro | 1982 |
A clinical trial of the beta blocker propranolol in premature ejaculation.
Topics: Adolescent; Adult; Anxiety; Blood Pressure; Chronic Disease; Ejaculation; Female; Heart Rate; Humans | 1984 |
[Use of the beta receptor blockader propranolol (Obsidan), in oral surgery].
Topics: Anxiety; Blood Pressure; Drug Evaluation; Female; Humans; Male; Placebos; Propranolol; Pulse; Tablet | 1980 |
Intravenous benztropine and propranolol challenges in tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Benztropine; Cross-Over Studies; Double-Blind Method; Dyski | 1993 |
Propranolol reduces the anxiety associated with day case surgery.
Topics: Adrenergic beta-Antagonists; Adult; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Anxiety; Do | 1996 |
Acute effects of beta blockade and exercise on mood and anxiety.
Topics: Adrenergic beta-Antagonists; Adult; Affect; Age Factors; Anxiety; Body Weight; Confusion; Depression | 1996 |
The effect of propranolol versus placebo on resident surgical performance.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Anxiety Agents; Anxiety; Cross-Over Studies; Double-Blind M | 1998 |
Antianxiety drug trials in hypertension [proceedings].
Topics: Anti-Anxiety Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertens | 1977 |
[Indications for beta-blockers in neurology].
Topics: Alcoholism; Antiparkinson Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Huma | 1978 |
[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
Topics: Anxiety; Bradycardia; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydroch | 1978 |
Oxprenolol and propranolol in anxiety states. A double-blind comparative study.
Topics: Adult; Anxiety; Clinical Trials as Topic; Depression, Chemical; Female; Heart Rate; Humans; Male; Mi | 1976 |
Propranolol in the treatment of anxiety.
Topics: Adolescent; Adult; Aged; Anxiety; Clinical Trials as Topic; Depression; Female; Humans; Male; Middle | 1976 |
A comparison of propranolol and diazepam for preoperative anxiolysis.
Topics: Adolescent; Adult; Anxiety; Bender-Gestalt Test; Blood Pressure; Diazepam; Dilatation and Curettage; | 1991 |
Influence of CGP 361A, propranolol and diazepam on autonomous reactions to different stressors.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Autonomic Nervous System; Blood Pressure; Diazepam; Dou | 1989 |
Beta-adrenergic blocking drugs in anxiety and stress.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Asthma; Benzodiazepine | 1985 |
An evaluation of once daily long acting propranolol hydrochloride (Inderal LA and Half-Inderal LA) in the treatment of anxiety. A double-blind placebo-controlled general practice study.
Topics: Adult; Anxiety; Clinical Trials as Topic; Delayed-Action Preparations; Depression; Double-Blind Meth | 1988 |
Alprazolam as an adjunct to propranolol in anxious outpatients with stable angina pectoris.
Topics: Adult; Aged; Alprazolam; Angina Pectoris; Anxiety; Benzodiazepines; Clinical Trials as Topic; Double | 1986 |
Migraine prophylaxis. A comparison of propranolol and amitriptyline.
Topics: Adult; Amitriptyline; Anxiety; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1987 |
A comparison of the effects of lorazepam with those of propranolol on experimentally-induced anxiety and performance.
Topics: Adult; Anxiety; Clinical Trials as Topic; Double-Blind Method; Emotions; Female; Humans; Lorazepam; | 1985 |
Effect of beta-receptor blockade on anxiety with reference to the three-systems model of phobic behavior.
Topics: Adult; Anxiety; Atenolol; Blood Pressure; Diastole; Double-Blind Method; Female; Heart Rate; Humans; | 1985 |
D-Propranolol and anxiety.
Topics: Anxiety; Humans; Propranolol; Stereoisomerism | 1971 |
Beneficial effect of beta-adrenergic blockade on "exam. nerves".
Topics: Adrenergic beta-Antagonists; Anxiety; Clinical Trials as Topic; Humans; Placebos; Propranolol; Stres | 1972 |
A dose-response study of propranolol in chronic schizophrenics.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Behavior; Blood Glucose; Blood Pressure; Calcium; Chron | 1973 |
The effect of propranolol on anxiety.
Topics: Anxiety; Clinical Trials as Topic; Humans; Placebos; Propranolol; Sympatholytics | 1966 |
Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol.
Topics: Antihypertensive Agents; Anxiety; Aspartate Aminotransferases; Blood Pressure; Clinical Trials as To | 1972 |
A controlled evaluation of propranolol in chronic alcoholic patients presenting the symptomatology of anxiety and tension.
Topics: Adult; Alcoholism; Anxiety; Clinical Trials as Topic; Female; Humans; Male; Placebos; Propranolol; P | 1973 |
Human relations: the uncontrolled variable in double-blind clinical trials.
Topics: Adult; Anxiety; Clinical Trials as Topic; Drug Therapy; Female; Humans; Hyperthyroidism; Interperson | 1973 |
Propranolol in neurotic and thyrotoxic anxiety.
Topics: Acoustic Stimulation; Anxiety; Anxiety Disorders; Attitude to Health; Clinical Trials as Topic; Eval | 1973 |
Anxiety and beta-adrenergic blockade.
Topics: Administration, Oral; Adult; Anxiety; Clinical Trials as Topic; Drug Evaluation; Emotions; Fatty Aci | 1973 |
Psychopharmacology.
Topics: Alcoholism; Anxiety; Brain Damage, Chronic; Chronic Disease; Clinical Trials as Topic; Depression; E | 1970 |
The psychological effects of propranolol in the abstinence phase of chronic alcoholics.
Topics: Adult; Alcoholism; Anxiety; Chlormethiazole; Chronic Disease; Clinical Trials as Topic; Diazepam; Hu | 1971 |
The use of propranalol in ECG diagnosis.
Topics: Adult; Anxiety; Diagnosis, Differential; Diazepam; Electrocardiography; Female; Heart Diseases; Hear | 1971 |
81 other studies available for propranolol and Anxiety
| Article | Year |
|---|---|
Myocardial hypersensitivity to ischemic injury is not reversed by clonidine or propranolol in a predator-based rat model of posttraumatic stress disorder.
Topics: Adrenergic Agents; Animals; Anxiety; Cardiovascular Agents; Clonidine; Disease Models, Animal; Disea | 2019 |
Interaction between morphine and noradrenergic system of basolateral amygdala on anxiety and memory in the elevated plus-maze test based on a test-retest paradigm.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amygdala; Analysis of Variance; An | 2013 |
Involvement of transmitters in the anxiolytic action of urocortin 3 in mice.
Topics: Analysis of Variance; Animals; Anxiety; Atropine; Bicuculline; Disease Models, Animal; Dose-Response | 2013 |
Anxiolytic action of neuromedin-U and neurotransmitters involved in mice.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anxiety; At | 2013 |
Transmitter mediation of the anxiolytic action of apelin-13 in male mice.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Atropine; Bicuculline; | 2014 |
Orexin A-induced anxiety-like behavior is mediated through GABA-ergic, α- and β-adrenergic neurotransmissions in mice.
Topics: Animals; Anxiety; Atropine; Behavior, Animal; Bicuculline; gamma-Aminobutyric Acid; Haloperidol; Int | 2014 |
Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats.
Topics: Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Arginine; Atropine; Bicuculli | 2015 |
Catechol-O-methyltransferase inhibition alters pain and anxiety-related volitional behaviors through activation of β-adrenergic receptors in the rat.
Topics: Adrenergic Agents; Analgesics; Animals; Anxiety; Catechol O-Methyltransferase; Catechol O-Methyltran | 2015 |
Progenitor cells are mobilized by acute psychological stress but not beta-adrenergic receptor agonist infusion.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Anxiety; Blood Pressure; CD3 Complex; | 2015 |
Adolescent social isolation increases anxiety-like behavior and ethanol intake and impairs fear extinction in adulthood: Possible role of disrupted noradrenergic signaling.
Topics: Aging; Alcohol Drinking; Animals; Anti-Anxiety Agents; Anxiety; Central Nervous System Depressants; | 2015 |
Anxiolytic effect of the GPR103 receptor agonist peptide P550 (homolog of neuropeptide 26RFa) in mice. Involvement of neurotransmitters.
Topics: Animals; Anxiety; Atropine; Bicuculline; Cyproheptadine; Haloperidol; Methysergide; Mice; Neuropepti | 2016 |
Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Dose-Response Relationship, Drug; Learning; Male; Midazolam; | 2008 |
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; | 2009 |
Hypokalemic periodic paralysis due to Graves Disease.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Anxiety; Arrhythmias, Cardiac; Dyspnea; Graves Di | 2009 |
The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics.
Topics: Administration, Inhalation; Animals; Anti-Anxiety Agents; Anxiety; Buspirone; Clonidine; Disease Mod | 2010 |
Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of beta 3 adrenoceptor activation.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepro | 2010 |
Early post-stressor intervention with propranolol is ineffective in preventing posttraumatic stress responses in an animal model for PTSD.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Behavior, Animal; Cues; Disease Models, Animal; Heart | 2011 |
Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Buspirone; Cocaine; Male; Motor Activity; O | 2012 |
The change in muscarinic receptor subtypes in different brain regions of rats treated with fluoxetine or propranolol in a model of post-traumatic stress disorder.
Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Anxiety; Blotting, Western; Brain Chemistry; Explora | 2012 |
Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; B7-2 Antigen; Catecholamines; CD11b Antigen; Cell Pro | 2012 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti- | 2003 |
Blood pressure and heart rate of students undergoing a medical licensing examination.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Anxiety; Blood Pressure; Educational Meas | 2004 |
Surviving a viva.
Topics: Anti-Anxiety Agents; Anxiety; Communication; Educational Measurement; Humans; Propranolol | 2005 |
Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Associatio | 2007 |
Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Behavior, Animal; Cocaine; Disease Models, Animal; Di | 2008 |
Caffeine poisoning and lactate rise: an overlooked toxic effect?
Topics: Adolescent; Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antidotes; Anxiety; Caffeine; Central | 2008 |
The influence of emotional stress on fat mobilization: the role of endogenous catecholamines and the beta adrenergic receptors.
Topics: Adult; Anxiety; Arousal; Catecholamines; Epinephrine; Fatty Acids; Female; Humans; Hypnosis; Lipid M | 1967 |
Sedative - hypnotic drugs.
Topics: Anti-Anxiety Agents; Anxiety; Barbiturates; Benzodiazepines; Histamine H1 Antagonists; Humans; Hypno | 1981 |
Once-a-day drug regimen for psychiatric patients.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Depressive Disorder; Drug Administratio | 1981 |
Beta adrenergic blockers in tremor.
Topics: Adrenergic beta-Antagonists; Anxiety; Humans; Oxprenolol; Parkinson Disease; Propranolol; Tremor | 1981 |
Effect of beta blockade and beta stimulation on stage fright.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anxiety; Double-Blind Method; Heart Rate; Hum | 1982 |
Propranolol, anxiety, and tardive dyskinesia.
Topics: Antipsychotic Agents; Anxiety; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Proprano | 1983 |
Panic attacks. Psychologic response or medical illness?
Topics: Adult; Antidepressive Agents; Anxiety; Autonomic Nervous System; Behavior Therapy; Fear; Female; Hum | 1984 |
Clonidine withdrawal complicated by amitriptyline therapy.
Topics: Aged; Amitriptyline; Anxiety; Clonidine; Female; Humans; Hypertension; Intraoperative Care; Methyldo | 1983 |
The effect of beta adrenergic blocking drugs on speakers' performance and memory.
Topics: Adult; Anxiety; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Propranolol; Speech | 1983 |
Abstinence syndrome from therapeutic doses of oxazepam.
Topics: Adult; Anxiety; Depression; Depressive Disorder; Diazepam; Fasciculation; Fear; Humans; Male; Oxazep | 1983 |
Psychosexual adjustment and counseling after myocardial infarction.
Topics: Adult; Anxiety; Counseling; Depression; Humans; Male; Myocardial Infarction; Propranolol; Sexual Beh | 1980 |
Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Atenolol; Cocaine; Injections, Intraperitoneal; Male; | 1993 |
Beta-adrenergic receptors are involved in stress-related behavioral changes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anxiety; Behavior, Animal; Corticost | 1993 |
Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Atropine; Bicuculline; | 1997 |
[Case presentation from behavior medicine].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior Therapy; Behavior, Animal; Defecation; Dogs; Female; | 1999 |
Influence of age, the autonomic nervous system and anxiety on QT-interval variability.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Analysis of Variance; Anti-Arrhythmia Agents; Anxie | 2001 |
Light-enhanced startle: further pharmacological and behavioral characterization.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxi | 2002 |
Proceedings: Clinical effects of beta-adrenergic blockers in psychiatry.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anxiety; Depression; Humans; Mental Disorders; Middl | 1975 |
Beta-adrenergic blocking drugs in anxiety.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety; Autonomic Nervous System; Drug Therapy, C | 1975 |
W E Dixon Memorial Lecture. Beta-adrenoceptor blockade in hyperthyroidism and anxiety.
Topics: Adrenergic beta-Antagonists; Anxiety; Central Nervous System; Humans; Hyperthyroidism; Oxprenolol; P | 1976 |
Present state of alpha and beta adrenergic drugs III. Beta blocking agents.
Topics: Adrenergic beta-Antagonists; Anxiety; Arrhythmias, Cardiac; Asthma; Heart Diseases; Humans; Hyperten | 1977 |
Drug treatment of anxiety.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Hum | 1978 |
Beta-adrenergic blockade and anxiety.
Topics: Adult; Anxiety; Humans; Isoproterenol; Male; Propranolol | 1976 |
Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog.
Topics: Amines; Amiodarone; Angina Pectoris; Animals; Anxiety; Behavior, Animal; Benzylamines; Conditioning, | 1978 |
Use of propranolol in dysfunctional labour.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Apgar Score; Birth Weight; Bradycardia; Catecholamines; | 1975 |
Somatic anxiety attacks and propranolol.
Topics: Adult; Anxiety; Blood Pressure; Female; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Propra | 1976 |
The effect of beta blockade on stress-induced cognitive dysfunction in adolescents.
Topics: Adolescent; Anxiety; Cognition Disorders; College Admission Test; Female; Humans; Male; Propranolol; | 1991 |
"The effect of beta blockade on stress-induced cognitive dysfunction in adolescents".
Topics: Adolescent; Anxiety; Cognition Disorders; College Admission Test; Humans; Propranolol; Stress, Psych | 1991 |
Stereoselectivity of the anxiolytic effect of propranolol microinjected into the dorsal midbrain central gray.
Topics: Animals; Anxiety; Exploratory Behavior; Male; Microinjections; Periaqueductal Gray; Propranolol; Rat | 1990 |
Characteristics of heart rate fluctuations and respiratory movements during orienting, passive avoidance and flight-fight behaviour in rabbits.
Topics: Animals; Anxiety; Atropine; Behavior, Animal; Electrocardiography; Electroshock; Fear; Female; Heart | 1990 |
Serotonergic mediation of the anxiolytic effect of intracerebrally injected propranolol measured in the elevated plus-maze.
Topics: Animal Testing Alternatives; Animals; Anxiety; Exploratory Behavior; Injections, Intraventricular; M | 1989 |
Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors.
Topics: 2-Chloroadenosine; Adenosine; Alprazolam; Anxiety; Caffeine; Chlordiazepoxide; Clonidine; Flumazenil | 1989 |
Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity.
Topics: Animals; Anxiety; Chlordiazepoxide; Clonidine; Learning; Male; Norepinephrine; Propranolol; Rats; Ra | 1989 |
Propranolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor.
Topics: Animals; Anxiety; Carbolines; Conditioning, Psychological; Corticotropin-Releasing Hormone; Fear; Fl | 1988 |
Effect of beta-blockers on psychomotor performance in normal volunteers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anxiety; Arousal; Atenolol; Diazepam; Drug Interacti | 1985 |
Management of anxiety in the elderly.
Topics: Aged; Anti-Anxiety Agents; Anxiety; Depression; Diagnosis, Differential; Female; Humans; Male; Propr | 1986 |
Beta-adrenoceptor blocking drugs in the treatment of morbid anxiety.
Topics: Adrenergic beta-Antagonists; Anxiety; Benzodiazepines; Biomechanical Phenomena; Humans; Propranolol | 1986 |
Differential effects of anxiolytics and beta-receptor blocking drugs on novelty-oriented ("neophobic") behavior in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Drin | 1988 |
Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeys.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Behavior, Animal; Blood Pressure; Carbolines; Clonidi | 1985 |
The peripheral and central role of the catecholamines in the mechanisms of anxiety.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Arousal; Benz | 1974 |
Cardiovascular events in anxiety in trained dogs: pharmacological aspects.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Blood Pressure; Cardiac Output; Coronary Vessels; Dogs; Heart | 1973 |
Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state.
Topics: Adult; Amobarbital; Anxiety; Female; Heart Rate; Humans; Hyperthyroidism; Injections, Intravenous; I | 1965 |
Combined parasympathetic and beta-receptor blockade as a clinical test.
Topics: Adolescent; Adult; Age Factors; Aged; Anemia; Anxiety; Atropine; Female; Fever; Heart Diseases; Hear | 1967 |
Trial of practolol (Eraldin) in treatment of supraventricular cardiac arrhythmias in the elderly.
Topics: Acetanilides; Administration, Oral; Adrenergic beta-Antagonists; Aged; Amino Alcohols; Anxiety; Arrh | 1970 |
Tranquillizing effects of propranolol demonstrated in rats.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Anxiety; Atropine; Central Nervous Syste | 1971 |
Cardiovascular events in anxiety: experimental studies in the conscious dog.
Topics: Animals; Anxiety; Aorta; Benzazepines; Blood Flow Velocity; Blood Pressure; Cardiac Output; Conditio | 1973 |
Inderal (propranolol) in the treatment of alcoholism.
Topics: Adult; Alcoholism; Anxiety; Humans; Propranolol; Substance Withdrawal Syndrome; Tremor | 1973 |
Effects of propranolol and chlordiazepoxide on conflict behavior in rats.
Topics: Animals; Anxiety; Behavior, Animal; Chlordiazepoxide; Conditioning, Operant; Conflict, Psychological | 1973 |
Letter: Response to propranolol and diazepam in somatic and psychic anxiety.
Topics: Anxiety; Anxiety Disorders; Diazepam; Humans; Propranolol; Psychophysiologic Disorders | 1974 |
Effects of systemic administration of propranolol on the timing behavior (DRL-20) of rats.
Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Conditioning, Operant; Depression, Chemical; Human | 1972 |
Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.
Topics: Animals; Anxiety; Behavior, Animal; Benzazepines; Brain; Depression, Chemical; Dopamine; Drug Antago | 1972 |
Verbal anxiety and the beta adrenergic receptors: a facilitating mechanism?
Topics: Adult; Anxiety; Chemoreceptor Cells; Fatty Acids; Feedback; Female; Humans; Propranolol; Stress, Psy | 1970 |
Final examinations.
Topics: Anxiety; Educational Measurement; Female; Fractures, Bone; Humans; Infectious Mononucleosis; Male; M | 1971 |
Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients.
Topics: Achilles Tendon; Adult; Aged; Anxiety; Epinephrine; Female; Fingers; Humans; Hyperthyroidism; Male; | 1968 |
Studies of amplitude variation in the ultra-low frequency ballistocardiogramwith special reference to cardiovascular reactivity.
Topics: Adult; Age Factors; Anxiety; Ballistocardiography; Body Height; Body Weight; Cardiac Output; Cardiov | 1969 |